Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting hedgehog signaling in pancreatic ductal adenocarcinoma
Delphine Quatannens, Yannick Verhoeven, Peter A. van Dam, et al.
Pharmacology & Therapeutics (2022) Vol. 236, pp. 108107-108107
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Structure–activity relationships for the G-quadruplex-targeting experimental drug QN-302 and two analogues probed with comparative transcriptome profiling and molecular modeling
Ahmed A. Ahmed, Shuang Chen, Maria Roman-Escorza, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Protein lipidation in cancer: mechanisms, dysregulation and emerging drug targets
Edward W. Tate, Lior Soday, Ana Losada de la Lastra, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 4, pp. 240-260
Closed Access | Times Cited: 16
Recent advances in drug delivery and targeting for the treatment of pancreatic cancer
Nilkamal Pramanik, Aditya K. Gupta, Yashwardhan Ghanwatkar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 231-260
Closed Access | Times Cited: 13
The role of Hedgehog and Notch signaling pathway in cancer
Ruolan Xia, Maosen Xu, Jing Yang, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 35
The Anticancer Effect of Napabucasin (BBI608), a Natural Naphthoquinone
Zeyang Shao, Heng Wang, Haiyan Ren, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5678-5678
Open Access | Times Cited: 20
Pancreatic cancer stemness: dynamic status in malignant progression
Yutong Zhao, Cheng Xue Qin, Bangbo Zhao, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 16
Therapeutic Approaches in Pancreatic Cancer: Recent Updates
Lokender Kumar, Sanjay Kumar, Sandeep Kumar, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1611-1611
Open Access | Times Cited: 16
Recent advances in cancer-associated fibroblast: Biomarkers, signaling pathways, and therapeutic opportunities
Donger Zhou, Lei Zheng
Chinese Medical Journal (2024) Vol. 137, Iss. 6, pp. 638-650
Open Access | Times Cited: 5
Are targeted therapies or immunotherapies effective in metastatic pancreatic adenocarcinoma?
Maxime Rémond, Anna Pellat, Catherine Brézault, et al.
ESMO Open (2022) Vol. 7, Iss. 6, pp. 100638-100638
Open Access | Times Cited: 19
Understanding the Roles of the Hedgehog Signaling Pathway during T-Cell Lymphopoiesis and in T-Cell Acute Lymphoblastic Leukemia (T-ALL)
Alberto M. Martelli, Francesca Paganelli, Serena Truocchio, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2962-2962
Open Access | Times Cited: 10
miR-301a-mediated crosstalk between the Hedgehog and HIPPO/YAP signaling pathways promotes pancreatic cancer
Bing Qi, Yuqiong Wang, Xian Zhu, et al.
Cancer Biology & Therapy (2025) Vol. 26, Iss. 1
Open Access
Histone Modifications Represent a Key Epigenetic Feature of Epithelial-to-Mesenchyme Transition in Pancreatic Cancer
Ying Xu, Qing Zhu
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4820-4820
Open Access | Times Cited: 9
Clinical and Preclinical Targeting of Oncogenic Pathways in PDAC: Targeted Therapeutic Approaches for the Deadliest Cancer
Diego J. Jiménez, Aadil Javed, Teresa Rubio‐Tomás, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2860-2860
Open Access | Times Cited: 3
MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen
Richard E. Kast, Alex Alfieri, Hazem Assi, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2563-2563
Open Access | Times Cited: 14
Gemcitabine and Pin1 siRNA co-delivery with fucoidan-coated nano-liposomes for therapy of pancreatic cancer
Zhenjiang Zheng, Dingchuan Peng, Mengfei Li, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104872-104872
Closed Access | Times Cited: 5
EZH2 as a potential therapeutic target for gastrointestinal cancers
Mehrdad Hashemi, Naghmeh Nazdari, Ghazaleh Gholamiyan, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 154988-154988
Closed Access | Times Cited: 4
Current approaches and strategies to identify Hedgehog signaling pathway inhibitors for cancer therapy
Zifan Feng, Shan‐Shan Zhu, Wenrui Li, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114867-114867
Closed Access | Times Cited: 7
Tumor microenvironment and redox dual stimuli-responsive polymeric nanoparticles for the effective cisplatin-based cancer chemotherapy
Yiyang Jia, Meng‐Lei Huan, Wei Wang, et al.
Nanotechnology (2022) Vol. 34, Iss. 3, pp. 035101-035101
Closed Access | Times Cited: 6
Kinesin family member 3A induces related diseases via wingless-related integration site/β-catenin signaling pathway
Shupeng Liu, Yang He, Shifeng Li, et al.
Science Progress (2023) Vol. 106, Iss. 1
Open Access | Times Cited: 3
Construction of tumor microenvironment and redox responsive nanocarrier-mediated cisplatin co-delivery system for effective chemotherapy to pancreatic cancer
Zhou-Yan Jia, Hao Zhou, Li‐Shuang Hou, et al.
Nano Futures (2022) Vol. 6, Iss. 2, pp. 025002-025002
Closed Access | Times Cited: 4
Research of immunotherapy in pancreatic cancer
Zetian Li
BIO Web of Conferences (2024) Vol. 111, pp. 02026-02026
Open Access
KRAS promotes GLI2-dependent transcription during pancreatic carcinogenesis
Ashley N. Sigafoos, Ezequiel J. Tolosa, Ryan M. Carr, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 7, pp. 1677-1689
Open Access
Advances in tumor stroma-based targeted delivery
Chunyan Wu, Yujia Zhai, Jianbo Ji, et al.
International Journal of Pharmaceutics (2024) Vol. 664, pp. 124580-124580
Closed Access
Unraveling the interplay: exploring signaling pathways in pancreatic cancer in the context of pancreatic embryogenesis
Sashikanta Swain, Ravi Kant Narayan, P Mishra
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Significance of Phytoconstituents in Modulating Cell Signalling Pathways for the Treatment of Pancreatic Cancer
Mayur Porwal, Vaibhav Rastogi, Phool Chandra, et al.
Revista Brasileira de Farmacognosia (2024)
Closed Access
Page 1 - Next Page

Scroll to top